Company intelligence / Profile preview

ViTAA Medical Solutions

Montreal, Quebec, Canadavitaamedical.com ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

ViTAA’s RAW™ Mapping technology is being validated in clinical studies and registry programs across North America. The platform non-invasively maps the strength and weakness of abdominal aortic aneurysms using AI analysis of cardiac-gated CT scans, providing actionable data for risk stratification. The company is pursuing regulatory approvals in Canada and the US, with initial commercial deployment through research use programs at multiple sites.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy (AI-powered diagnostic software)
Industry: Medical Imaging

Partnerships

University of Calgary (technology development/collaboration)UCeed Health Fund/UCalgary innovation ecosystem investment partner

Beyond the preview

Go deeper on ViTAA Medical Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViTAA Medical Solutions.

Explore the full profile